The global HIV Diagnosis Market was valued at USD 2.8 billion in 2016 and is projected to reach USD 6.66 billion by 2025, growing at a CAGR of 10.1% from 2017 to 2025.
HIV tests are used to detect the presence of the human immunodeficiency virus, the virus that causes acquired immunodeficiency syndrome, in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA. Increasing incidences of transfusing Unapproved or untested blood samples and other possible vector for HIV is causing the need of HIV diagnosis to rise.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Patient count of HIV-AIDS
1.2 Growing incidences of blood transfusions and blood donation
1.3 Advantage of using Point-of-care kits
1.4 Increasing support from Govt.
2. Market Restraints
2.1 High cost
2.2 Lack of Regulations
Market Segmentation:
1. Global HIV Diagnosis Market, by Test Type:
1.1 Antibody Tests
1.1.1 HIV-1 Screening Tests
1.1.1.1 Elisa
1.1.1.2 Rapid Tests
1.1.1.3 Home Access Dried Blood Spots
1.1.2 HIV-1 Antibody Confirmatory Tests
1.1.2.1 Western Blot Tests
1.1.2.2 Indirect Immunofluorescence Assays (IFA)
1.1.2.3 Line Immunoassays
1.1.2.4 Radio-Immunoprecipitation Assays
1.1.3 HIV-2 & Group O Diagnostic Tests
1.2 Viral Load Tests
1.3 CD4 Tests
1.4 Tests for Early Infant Diagnosis
1.5 Tests for Viral Identification
2. Global HIV Diagnosis Market, by Product:
2.1 Consumables
2.1.1 Assays and Kits & Reagents
2.1.2 Other Consumables
2.2 Instruments
2.3 Software & Services
3. Global HIV Diagnosis Market, by End User:
3.1 Diagnostic Laboratories
3.2 Hospitals
3.3 Blood Banks
3.4 Home Care Settings
3.5 Other End Users
4. Global HIV Diagnosis Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Siemens Healthineers (A Division of Siemens AG)
2. Roche Diagnostics (Division of Hoffman La Roche Ltd.)
3. Abbott Laboratories
4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
5. Thermo-Fisher Scientific Inc.
6. Merck KGaA
7. Becton, Dickinson & Company
8. Hologic Inc.
9. Alere Inc.
10. Bio-Rad Laboratories
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the HIV Diagnosis Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL HIV DIAGNOSIS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HIV DIAGNOSIS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global HIV Diagnosis Market, by Test Type:
5.1 Antibody Tests
5.1.1 HIV-1 Screening Tests
5.1.1.1 Elisa
5.1.1.2 Rapid Tests
5.1.1.3 Home Access Dried Blood Spots
5.1.2 HIV-1 Antibody Confirmatory Tests
5.1.2.1 Western Blot Tests
5.1.2.2 Indirect Immunofluorescence Assays (IFA)
5.1.2.3 Line Immunoassays
5.1.2.4 Radio-Immunoprecipitation Assays
5.1.3 HIV-2 & Group O Diagnostic Tests
5.2 Viral Load Tests
5.3 CD4 Tests
5.4 Tests for Early Infant Diagnosis
5.5 Tests for Viral Identification
6 Global HIV Diagnosis Market, by Product:
6.1 Consumables
6.1.1 Assays and Kits & Reagents
6.1.2 Other Consumables
6.2 Instruments
6.3 Software & Services
7 Global HIV Diagnosis Market, by End User:
7.1 Diagnostic Laboratories
7.2 Hospitals
7.3 Blood Banks
7.4 Home Care Settings
7.5 Other End Users
8 GLOBAL HIV DIAGNOSIS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL HIV DIAGNOSIS MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Siemens Healthineers
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Roche Diagnostics
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Abbott Laboratories
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Beckman Coulter, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Thermo-Fisher Scientific Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Merck KGaA
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Becton, Dickinson & Company
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Hologic Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Alere Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Bio-Rad Laboratories
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports
The Third-party Pathology Diagnosis Center Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Myocarditis Treatment and Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Concussion Treatment and Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Image-based FFR Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Donor Transfusion Diagnosis Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together...
Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...
Europe connected healthcare device market was valued at $16 billion in 2023 and will grow by 19.2% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and inte...
North America connected healthcare device market is projected to grow by 18.9% annually in the forecast period and reach $106.9 billion by 2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrati...
Global connected healthcare device market will reach $338.6 billion by 2033, growing by 19.5% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and internet ...